Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals To Buy Casper Pharma For $20.5 Mln

April 5 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * TO BUY ENTIRE SHARE CAPITAL FROM EXISTING SHAREHOLDERS OF
CASPER
PHARMA
    * DEAL FOR $20.5 MILLION

Source text for Eikon:  ID:nBSE8V9GtF 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news